(Q53972232)

23 May 2018

title

Phenotypic transformation of CD52(pos) to CD52(neg) leukemic T cells as a mechanism for resistance to CAMPATH-1H. (English)

1 reference

23 May 2018

1 reference

R E Birhiray

1

1 reference

23 May 2018

G Shaw

2

1 reference

23 May 2018

S Guldan

3

1 reference

23 May 2018

D Rudolf

4

1 reference

23 May 2018

D Delmastro

5

1 reference

23 May 2018

P Santabarbara

6

1 reference

23 May 2018

L Brettman

7

1 reference

23 May 2018

publication date

1 May 2002

1 reference

23 May 2018

published in

Leukemia

1 reference

23 May 2018

volume

16

1 reference

23 May 2018

issue

5

1 reference

23 May 2018

page(s)

861-864

1 reference

23 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402471

exact match

0 references

cites work

Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

The CAMPATH-1 antigen (CDw52)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Campath-1H therapy in refractory ocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

T-cell Prolymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402471

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402471

1 reference

23 May 2018

PubMed ID

11986948

1 reference

23 May 2018